Late-Window Stroke: Hyperglycemia Doesn’t Alter EVT Benefit
The International Journal of Stroke recently shared a post on X:
”Just Accepted! Study in those with acute ischemic stroke and large vessel occlusion of the anterior circulation. Results show hyperglycaemia does not modify the efficacy of endovascular therapy in the late time window.”
Read the full article here.
Hyperglycemia has long been the unwelcome guest at the stroke table, often associated with worse outcomes and suspected of meddling with treatment effects—especially in early endovascular therapy (EVT).
Naturally, one might expect it to play a similarly disruptive role in patients treated in the late window (6 to 24 hours after symptom onset or last known well).
But in the study of anterior circulation large vessel occlusion stroke, Clemens Kersten et al. showed that hyperglycemia had surprisingly little to say.
Regardless of admission glucose levels, the benefit of EVT remained unchanged.
In conclusion, no evidence that admission glucose or hyperglycemia modifies the benefit of EVT in this population, suggesting EVT efficacy remains consistent across a range of glucose levels in the late window setting.
Stay updated on the advancements in science in the field of thrombosis with Hemostasis Today.
-
Jul 5, 2025, 17:24Bleeding Disorders in 2035: Michael Makris is Future-Focused at HABIT Summit 2025
-
Jul 5, 2025, 16:32EHC Unveils New ERIN Identity: Supporting Individuals with Extremely Rare Bleeding Disorders
-
Jul 5, 2025, 16:30Calling Physiotherapists: Contribute to Shaping Care for Women with Bleeding Disorders by Sharing Insights on Physical Health and Physiotherapy
-
Jul 5, 2025, 16:26Access ISTH 2025 Congress On-Demand: 30 Days of Virtual Learning Available Now
-
Jul 5, 2025, 16:17Thrombosis Canada Wants Your Voice: Did You Know 1 in 5 Cancer Patients Will Experience a Blood Clot (VTE)?
-
Jul 6, 2025, 16:23Metabolic Reprogramming in Deep Vein Thrombosis: A Novel Therapeutic Avenue Beyond Anticoagulation
-
Jul 5, 2025, 17:38Late-Window Stroke: Hyperglycemia Doesn’t Alter EVT Benefit
-
Jul 5, 2025, 17:33Discharged, But Not Safe: Uncovering Hidden Risks of Anticoagulation for Post-Hospital Bleeding
-
Jul 2, 2025, 16:51Research Tuesday from SVIN: IV Thrombolysis in Cervical Artery Dissection—A Safer Path Home?
-
Jul 2, 2025, 05:34Redefining Life with Catastrophic Antiphospholipid Syndrome: Mark Hall’s Journey at U-M Health
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jun 30, 2025, 15:31Don’t Miss the Advanced Haemostasis and Thrombosis Course Led by Expert Tutors - Blood Academy
-
Jun 26, 2025, 14:33ISTH Pulse Podcast Episode with Vasculearn Network
-
Jun 22, 2025, 11:27The ISTH Congress Daily News Team Interviews Rob Montgomery